Status:
RECRUITING
The Effect of Different Music Listened During Retinopathy Examination to Premature Infants
Lead Sponsor:
Necmettin Erbakan University
Conditions:
Retinopathy of Prematurity
Newborn
Eligibility:
All Genders
28-36 years
Phase:
NA
Brief Summary
Retinopathy of Prematurity (ROP); It is a disease of premature and low birth weight infants, characterized by incomplete vascularization of the retina, etiology and pathogenesis of which is unknown, a...
Detailed Description
Retinopathy of Prematurity (ROP); It is a disease characterized by incomplete vascularization of the retina seen in premature and low birth weight infants, the etiology and pathogenesis of which are u...
Eligibility Criteria
Inclusion
- • Gestational age ≤34 weeks
- Birth Weight ≤2000 grams
- Preterm newborns with a corrected/postnatal age of 28-36 weeks at the time of examination
- Having the baby's first ROP examination
- Not giving sedative, opioid and anticonvulsant drugs before/during the examination
- Parents do not have diagnosed mental or mental problems and agree to participate in the research.
Exclusion
- Presence of a condition that prevents pain assessment (intracranial hemorrhage, neuromotor developmental retardation, etc.)
- Oxygen requirement (nasal cannula, hood or incubator)
- Having any congenital defect (eye, neurological) that may adversely affect the examination
- Having a diagnosed hearing loss
- Performing a different painful procedure at least one hour before the ROP
- Being connected to a mechanical ventilator
- Congenital hearing problems in family members
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05967572
Start Date
June 1 2023
End Date
July 1 2024
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)